RxDoctor Payments Data

Justin Iorio, MD

Orthopaedic Surgery of the Spine · Syracuse, NYNPI 1225359532

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $86,904 of the $119,350 with a category attached, or 72.8%. 12 manufacturers reported payments, led by Surgentec at 52.1% of the total. 2025 is the largest year on record at $54,295, 4.8 times the $11,239 reported in 2019.

$119,350in general payments, 2019–2025

Across 79 payments — averaging $1510.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgentec$62K
  • Spine Wave, Inc.$25K
  • Medicrea USA, Corp.$17K
  • Alphatec Spine, Inc$7K
  • Trackx Technology, Inc.$7K
  • Zimvie Inc.$927
  • plus $447 from 6 others
$3,000in research payments, 2019–2025

Across 10 payments — averaging $300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$3K

What the payments were for

  • Royalty or licence$86,90473%
  • Consulting fees$19,02516%
  • Speaking & faculty fees$1,6991%
  • Travel & lodging$8,3537%
  • Food & beverage$3,1803%
  • Entertainment$1880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Surgentec9$62,176
Spine Wave, Inc.18$24,910
Medicrea USA, Corp.8$17,226
Alphatec Spine, Inc26$6,922
Trackx Technology, Inc.3$6,742
Zimvie Inc.4$927
Intrinsic Therapeutics4$166
Johnson & Johnson1$113
Medtronic(2 entities)3$112
Aesculap, Inc.1$24
Smith+Nephew1$17
Globus Medical1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$119,350 in reported general payments places this provider in the 80th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$261,549
Medicare patients
302
Services billed
1,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin63$501
Celecoxib27$312
Methylprednisolone51$293
Diclofenac Sodium18$192
Oxycodone Hcl35$154
Meloxicam73$144
Mupirocin19$128
Naproxen16$92
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$77
Ciprofloxacin Hcl11$68
Tizanidine Hcl22$44
Cyclobenzaprine Hcl24$36
Diazepam11$13

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →